Premium
Understanding of Molecular Substructures that Contribute to hERG K + Channel Blockade: Synthesis and Biological Evaluation of E‐4031 Analogues
Author(s) -
Vilums Maris,
Overman Jeroen,
Klaasse Elisabeth,
Scheel Olaf,
Brussee Johannes,
IJzerman Adriaan P.
Publication year - 2012
Publication title -
chemmedchem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.817
H-Index - 100
eISSN - 1860-7187
pISSN - 1860-7179
DOI - 10.1002/cmdc.201100366
Subject(s) - herg , chemistry , potassium channel blocker , drug discovery , potassium channel , moiety , radioligand , amide , stereochemistry , small molecule , structure–activity relationship , combinatorial chemistry , pharmacology , biophysics , biochemistry , binding site , in vitro , potassium , biology , medicine , organic chemistry
Cardiotoxicity is a common side effect of a large variety of drugs that is often caused by off‐target human ether‐à‐go‐go‐related gene (hERG) potassium channel blockade. In this study, we designed and synthesized a series of derivatives of the class III antiarrhythmic agent E‐4031. These compounds where evaluated in a radioligand binding assay and automated patch clamp assay to establish structure–activity relationships (SAR) for their inhibition of the hERG K + channel. Structural modifications of E‐4031 were made by altering the peripheral aromatic moieties with a series of distinct substituents. Additionally, we synthesized several derivatives with a quaternary nitrogen and modified the center of the molecule by introduction of an additional nitrogen and deletion of the carbonyl oxygen. Some modifications caused a great increase in affinity for the hERG K + channel, while other seemingly minor changes led to a strongly diminished affinity. Structures with quaternary amines carrying an additional aromatic moiety were found to be highly active in radioligand binding assay. A decrease in affinity was achieved by introducing an amide functionality in the central scaffold without directly interfering with the p K a of the essential basic amine. The knowledge gained from this study could be used in early stages of drug discovery and drug development to avoid or circumvent hERG K + channel blockade, thereby reducing the risk of cardiotoxicity, related arrhythmias and sudden death.